Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: MOLECULAR EXPRESS, INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-06-01 to 2022-05-31
Current total value of award: $299961
Description: EO14042: THE OBJECTIVE OF THIS CONTRACT IS TO IDENTIFY A POTENTIAL HIV ANTIGEN-CONJUGATED VACCINE FORMULATION BY EXPLORING CO-DELIVERY OF HIV ANTIGENS AND ADJUVANT MOLECULES.